The causative or triggering agents for endometrial cancer remain elusive despite continued research along the PI3K/PTEN/mTOR/HIF axis in type I [1] and the p53 tumor-suppressor system in type II endometrial cancer [2]. Here, MTOR is linked to endometrial cancer.